Serum bilirubin level is inversely associated with nonalcoholic steatohepatitis in children

Journal of Pediatric Gastroenterology and Nutrition

Volumn 57, Issue 1, 2013, Pages 114-118

  Puri, Kanika ^a   Nobili, Valerio ^c   Melville, Katherine ^b   Corte, Claudia D ^c   Sartorelli, Maria R ^c   Lopez, Rocio ^b   Feldstein, Ariel E ^d   Alkhouri, Naim ^b  

^a SUNY DOWNSTATE MEDICAL CENTER   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c BAMBINO GESÙ CHILDREN S HOSPITAL   (Italy)

^d RADY CHILDREN'S HOSPITAL   (United States)

Author keywords

Antioxidant; Bilirubin; Children; Histology; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Indexed keywords

BILIRUBIN;

ADOLESCENT; ARTICLE; BILIRUBIN BLOOD LEVEL; CELL PROTECTION; CHILD; COMPARATIVE STUDY; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER FIBROSIS; LIVER HISTOLOGY; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE ANALYSIS; NONALCOHOLIC FATTY LIVER; NONALCOHOLIC FATTY LIVER DISEASE ACTIVITY SCORE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ALLOSTASIS; ANTIOXIDANTS; BILIRUBIN; BIOPSY; BODY MASS INDEX; CHILD; FATTY LIVER; HEPATITIS; HUMANS; HYPERBILIRUBINEMIA; LIVER; LIVER CIRRHOSIS; LOGISTIC MODELS; METABOLIC SYNDROME X; OBESITY; SEVERITY OF ILLNESS INDEX;

EID: 84879889434     PISSN: 02772116     EISSN: 15364801     Source Type: Journal    
DOI: 10.1097/MPG.0b013e318291fefe     Document Type: Article

References (33)

1. Pacifico L, Nobili V, Anania C, et al. Pediatric nonalcoholic fatty liver disease, metabolic syndrome and cardiovascular risk. World J Gastroenterol 2011;17: 3082-91.
2. Schwimmer JB, Deutsch R, Rauch JB, et al. Obesity, insulin resistance, and other clinicopathological correlates of pediatric nonalcoholic fatty liver disease. J Pediatr 2003;143: 500-5.
3. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of obesity and trends in body mass index among US children and adolescents, 1999-2010. JAMA 2012;307: 483-90.
4. Day CP, James OFW. Steatohepatitis: a tale of two. Gastroenterology 1998;114: 842-5.
5. Tilg H, Moschen AR. Evolution of inflammation in nonalcoholic fatty liver disease: the multiple parallel hits hypothesis. Hepatology 2010;52: 1836-46.
6. Malaguarnera M, Di Rosa M, Nicoletti F, et al. Molecular mechanisms involved in NAFLD progression. J Mol Med 2009;87: 679-95.
7. Alisi A, Cianfarani S, Manco M, et al. Non-alcoholic fatty liver disease and metabolic syndrome in adolescents: pathogenetic role of genetic background and intrauterine environment. Ann Med 2012; 44: 29-40.
8. Stocker R, Yamamoto Y, McDonagh AF, et al. Bilirubin is an antioxidant of possible physiological importance. Science 1987;235: 1043-6.
9. Stocker R. Antioxidant activities of bile pigments. Antioxid Redox Signal 2004;6: 841-9.
10. Baranano DE, Rao M, Ferris CD, et al. Biliverdin reductase: a major physiologic cytoprotectant. Proc Natl Acad Sci U S A 2002; 99: 16093-8.
11. Neuzil J, Stocker R. Free and albumin-bound bilirubin are efficient co-antioxidants for alpha-tocopherol, inhibiting plasma and low density lipoprotein lipid peroxidation. J Biol Chem 1994;269: 16712-9.
12. Sedlak TW, Snyder SH. Bilirubin benefits: cellular protection by a biliverdin reductase antioxidant cycle. Pediatrics 2004;113: 1776-82.
13. Mayer M. Association of serum bilirubin concentration with risk of coronary artery disease. Clin Chem 2000;46: 1723-7.
14. Perlstein TS, Pande RL, Beckman JA, et al. Serum total bilirubin level and prevalent lower-extremity peripheral arterial disease: National Health and Nutrition Examination Survey (NHANES) 1999 to 2004. Arterioscler Thromb Vasc Biol 2008;28: 166-72.
15. Lin LY, Kuo HK, Hwang JJ, et al. Serum bilirubin is inversely associated with insulin resistance and metabolic syndrome among children and adolescents. Atherosclerosis 2009;203: 563-8.
16. Lin YC, Chang PF, Hu FC, et al. Variants in the UGT1A1 gene and the risk of pediatric nonalcoholic fatty liver disease. Pediatrics 2009; 124:e1221-7.
17. Kumar R, Rastogi A, Maras J, et al. Unconjugated hyperbilirubinemia in patients with non-alcoholic fatty liver disease: a favorable endogenous response. Clin Biochem 2011;45: 272-4.
18. Nobili V, Marcellini M, Devito R, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. Hepatology 2006;44: 458-65.
19. Manco M, Bedogni G, Marcellini M, et al. Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 2008;57: 1283-7.
20. Cole TJ, Bellizzi MC, Flegal KM, et al. Establishing a standard definition for child overweight and obesity worldwide: international survey. BMJ 2000;320: 1240-3.
21. Boney CM, Verma A, Tucker R, et al. Metabolic syndrome in childhood: association with birth weight, maternal obesity, and gestational diabetes mellitus. Pediatrics 2005;115:e290-6.
22. Fernández JR, Redden DT, Pietrobelli A, et al. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr 2004;145: 439-44.
23. American Academy of Pediatrics. National Cholesterol Education Program: report of the Expert Panel on Blood Cholesterol Levels in Children and Adolescents. Pediatrics 1992;89 (3 Pt 2): 525-84.
24. Report of the Second Task Force on Blood Pressure Control in Children - 1987Task Force on Blood Pressure Control in Children. National Heart, Lung, and Blood Institute, Bethesda, Maryland. Pediatrics 1987;79: 1-25.
25. Genuth S, Alberti K, Bennett P, et al. Follow-up report on the diagnosis of diabetes mellitus. Diabetes care 2003;26:3160.
26. Matthews D, Hosker J, Rudenski A, et al. Homeostasis model assessment: insulin resistance and b-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28: 412-9.
27. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22: 1462-70.
28. Katz A, Nambi SS, Mather K, et al. Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans. J Clin Endocrinol Metab 2000;85: 2402-10.
29. Poynard T, Halfon P, Castera L, et al. Variability of the area under the receiver operating characteristic curves in the diagnostic evaluation of liver fibrosis markers: impact of biopsy length and fragmentation. Aliment Pharmacol Ther 2007;25: 733-9.
30. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41: 1313-21.
31. Chang Y, Ryu S, Zhang Y, et al. A cohort study of serum bilirubin levels and incident non-alcoholic fatty liver disease in middle aged Korean workers. PloS ONE 2012;7:e37241.
32. Hjelkrem M, Morales A, Williams CD, et al. Unconjugated hyperbilirubinemia is inversely associated with non-alcoholic steatohepatitis (NASH). Aliment Pharmacol Ther 2012;35: 1416-23.
33. Shepherd R, Moreno F, Cashore W, et al. Effects of bilirubin on fat cell metabolism and lipolysis. Am J Physiol 1979;237:E504-8.